Reference is made to the stock exchange notices published by Ultimovacs ASA (the "Company") on (i) 17 December 2024 ...
The Company announces that on 8 January 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1296 pence per share. Further details are set out below: ...
EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...
Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA POSTS RECORD SALES OF CHF 11.76 BILLION IN 2024 -- ...
The Australian market is trading notably lower on Thursday, snapping a five-session winning session, following the mixed cues from ...
Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...
GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...
The Taiwan stock market has climbed higher in consecutive trading days, accelerating more than 700 points or 2.9 percent along the ...
The China stock market has finished lower in four straight sessions, plummeting more than 200 points or 6 percent in that span. The ...
The Hong Kong stock market has alternated between positive and negative finishes through the last four trading days since the end of ...
After moving to the upside early in the session, the price of crude oil gave back ground over the course of the trading day on ...